Ahmad, T.; Ishaq, M.; Karpiniec, S.; Park, A.; Stringer, D.; Singh, N.; Ratanpaul, V.; Wolfswinkel, K.; Fitton, H.; Caruso, V.;
et al. Oral Macrocystis pyrifera Fucoidan Administration Exhibits Anti-Inflammatory and Antioxidant Properties and Improves DSS-Induced Colitis in C57BL/6J Mice. Pharmaceutics 2022, 14, 2383.
https://doi.org/10.3390/pharmaceutics14112383
AMA Style
Ahmad T, Ishaq M, Karpiniec S, Park A, Stringer D, Singh N, Ratanpaul V, Wolfswinkel K, Fitton H, Caruso V,
et al. Oral Macrocystis pyrifera Fucoidan Administration Exhibits Anti-Inflammatory and Antioxidant Properties and Improves DSS-Induced Colitis in C57BL/6J Mice. Pharmaceutics. 2022; 14(11):2383.
https://doi.org/10.3390/pharmaceutics14112383
Chicago/Turabian Style
Ahmad, Tauseef, Muhammad Ishaq, Samuel Karpiniec, Ahyoung Park, Damien Stringer, Neeraj Singh, Vishal Ratanpaul, Karen Wolfswinkel, Helen Fitton, Vanni Caruso,
and et al. 2022. "Oral Macrocystis pyrifera Fucoidan Administration Exhibits Anti-Inflammatory and Antioxidant Properties and Improves DSS-Induced Colitis in C57BL/6J Mice" Pharmaceutics 14, no. 11: 2383.
https://doi.org/10.3390/pharmaceutics14112383
APA Style
Ahmad, T., Ishaq, M., Karpiniec, S., Park, A., Stringer, D., Singh, N., Ratanpaul, V., Wolfswinkel, K., Fitton, H., Caruso, V., & Eri, R.
(2022). Oral Macrocystis pyrifera Fucoidan Administration Exhibits Anti-Inflammatory and Antioxidant Properties and Improves DSS-Induced Colitis in C57BL/6J Mice. Pharmaceutics, 14(11), 2383.
https://doi.org/10.3390/pharmaceutics14112383
